
-
Iran executed at least 1,000 this year in prison 'mass killing': NGO
-
France's Dassault says can build European fighter jet without Germany
-
Former umpire 'Dickie' Bird dies aged 92
-
Ghana deports at least six west Africans expelled by US to Togo
-
Bradley admits thoughts linger about having played in Ryder Cup
-
EU queries Apple, Google, Microsoft over financial scams
-
OECD raises world growth outlook as tariffs contained, for now
-
Former umpire Harold 'Dickie' Bird dies aged 92
-
Cycling worlds bring pride to African riders despite disadvantages
-
Stocks diverge with eyes on key economic data
-
German business groups pressure Merz over ailing economy
-
Drone flights 'most serious attack' on Danish infrastructure, PM says
-
Indonesia, EU sign long-awaited trade deal
-
Howe confident Newcastle will find 'X factor'
-
Trump returns to UN podium and Zelensky talks
-
Tech migrants 'key' for US growth, warns OECD chief economist
-
East Timor to become ASEAN bloc's 11th member in October
-
OECD ups world economic outlook as tariffs contained, for now
-
India bids tearful farewell to maverick musician
-
Sunset for Windows 10 updates leaves users in a bind
-
Hopes of Western refuge sink for Afghans in Pakistan
-
'Real' Greek farmers fume over EU subsidies scandal
-
Trump to see Zelensky and lay out dark vision of UN
-
US lawmaker warns of military 'misunderstanding' risk with China
-
Emery seeks Europa League lift with Villa as Forest end long absence
-
Egypt frees activist Alaa Abdel Fattah after Sisi pardon
-
Gibbs, Montgomery doubles as Lions rampage over Ravens
-
Asian markets struggle as focus turns to US inflation
-
Schools shut, flights cancelled as Typhoon Ragasa nears Hong Kong
-
Maverick Georgian designer Demna debuts for Gucci in Milan
-
What do some researchers call disinformation? Anything but disinformation
-
Jimmy Kimmel show to return Tuesday
-
Unification Church leader arrested in South Korea
-
U.S. Polo Assn. Supports the XV Federation of International Polo European Polo Championship as Official Apparel Partner
-
Singapore firm rejects $1bn Sri Lankan pollution damages
-
Chile presidential contender vows to deport 'all' undocumented migrants
-
China may strengthen climate role amid US fossil fuel push
-
Ryder Cup captains play upon emotions as practice begins
-
Bradley defends US Ryder Cup player payments as charity boost
-
Trump ties autism risk to Tylenol as scientists urge caution
-
Dembele beats Yamal to Ballon d'Or as Bonmati retains women's award
-
Strength in Nvidia, Apple helps lift US equities to new records
-
Man City 'keeper Donnarumma says would have stayed at PSG
-
49ers ace Bosa to miss season after knee injury: reports
-
Canada wildlife decline 'most severe' in decades: WWF
-
PSG star Dembele wins men's Ballon d'Or
-
Napoli beat battling Pisa to maintain perfect Serie A start
-
Spain's Aitana Bonmati wins Women's Ballon d'Or
-
Jimmy Kimmel show to return Tuesday: Disney
-
Marseille inflict first defeat of season on PSG in Ligue 1

Disgraced surgeon on trial in Sweden over windpipe transplants
An Italian doctor who made headlines for pioneering windpipe surgery went on trial in Sweden on Wednesday, charged with assault for performing the experimental procedure.
Paolo Macchiarini won praise in 2011 after claiming to have performed the world's first synthetic trachea transplants using stem cells while he was a surgeon at Stockholm's Karolinska Institute.
The procedure was hailed as a breakthrough in regenerative medicine.
But allegations soon emerged that the risky procedure had been carried out on at least one person who had not been critically ill at the time of the operation.
The 63-year-old appeared in court in a blue suit Wednesday, where he listened to translated audio as prosecutors listed the charges of "aggravated assault" against three patients.
- 'Disregard for science' -
The Karolinska Institute has confirmed that the three individuals have since died, but did not directly link the deaths to the operations.
"Macchiarini has carried out the surgery with complete disregard for science and tried experience," prosecutor Karin Lundstrom-Kron told the court.
As prosecutors presented their case they referenced both external and internal reviews of the case, including one published in 2016 by physician Kjell Asplund, who argued that Macchiarini should never have been employed by Karolinska in the first place.
"It is clear that this method has not worked," prosecutor Jim Westerberg said, adding that Macchiarini had embellished the benefits of the procedure.
Macchiarini, who took notes without showing much emotion, has maintained the operations constituted treatments and not experiments, and denied being criminally responsible.
"He contends that he has performed health care, cured and helped," Macchiarini's lawyer Bjorn Hurtig told AFP during a recess.
The prosecution's presentation of evidence is expected to continue over several days so the defence will likely not be able to present its side until next week.
But Hurtig said they had "high hopes" they would be able to counter the prosecution's evidence.
"There are quite a lot of gaps in that evidence and there is a lot of evidence that we argue are favourable to our view of things," he said.
- Downplayed risks -
In 2013, the Karolinska hospital suspended all transplants and refused to extend Macchiarini's contract as a surgeon.
A year later, several surgeons at the hospital filed a complaint alleging that Macchiarini had downplayed the risks of the procedure.
Macchiarini carried out three surgeries at Karolinska University Hospital in 2011 and 2012, using an artificial windpipe made of plastic and coating it with the patient's own stem cells.
Together with his colleagues, he performed a total of eight such transplants between 2011 and 2014, the five others taking place in Russia.
An external review in 2015 found Macchiarini guilty of research misconduct, but despite sacking him, the Karolinska Institute repeatedly defended him until 2018, when it found him and several other researchers guilty.
The university's principal stepped down over the scandal, as well as a number of other people.
Medical journal The Lancet in 2018 retracted two papers authored by Macchiarini.
The trial, held in the Solna district court near the Karolinska Institute, is scheduled to take place over 13 days.
S.Abdullah--SF-PST